Tertiary lymphoid structures and their therapeutic implications in cancer
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00975-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Oncology, 2024. Verfasst von Xun Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiang…. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates formed by the structured accumulation of immune cells such as B cells and T cells in non-lymphoid tissues induced by infection, inflammation, and tumors. They play a crucial role in the immune response, particularly in association with tumor development, where they primarily exert anti-tumor immune functions during tumorigenesis. Current research suggests that TLSs inhibit tumor growth by facilitating immune cell infiltration and are correlated with favorable prognosis in various solid tumors, serving as an indicator of immunotherapy effectiveness to some extent. Therefore, TLSs hold great promise as a valuable biomarker. Most importantly, immunotherapies aimed to prompting TLSs formation are anticipated to be potent adjuncts to current cancer treatment. This review focuses on the formation process of TLSs and their potential applications in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
- Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China.
- Departments of Cancer Research Institute, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
- Xinjiang Key Laboratory of Translational Biomedical Engineering, Urumqi, China.
- Departments of Cancer Research Institute, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China. wenjiaguo@xjmu.edu.cn.
- Xinjiang Key Laboratory of Translational Biomedical Engineering, Urumqi, China. wenjiaguo@xjmu.edu.cn.
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Chen, X., Wu, P., Liu, Z., Li, T., Wu, J., Zeng, Z., Guo, W., & Xiong, W. (2024). Tertiary lymphoid structures and their therapeutic implications in cancer. Cellular Oncology. https://doi.org/10.1007/s13402-024-00975-1
Vancouver
Chen X, Wu P, Liu Z, Li T, Wu J, Zeng Z, et al. Tertiary lymphoid structures and their therapeutic implications in cancer. Cellular Oncology. 2024. doi:10.1007/s13402-024-00975-1
BibTeX
@article{Chen2024,
author = {Chen, Xun and Wu, Pan and Liu, Ziqi and Li, Tiansheng and Wu, Jie and Zeng, Zhaoyang and Guo, Wenjia and Xiong, Wei},
title = {Tertiary lymphoid structures and their therapeutic implications in cancer},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00975-1}
}
EUVIMED